Impax Laboratories Inc (NASDAQ:IPXL)

19.90
Delayed Data
As of 4:00pm ET
 -0.30 / -1.49%
Today’s Change
12.50
Today|||52-Week Range
25.70
+19.52%
Year-to-Date
No recent news for Impax Laboratories Inc.

Today’s Trading

Previous close20.20
Today’s open20.10
Day’s range19.75 - 20.60
Volume754,920
Average volume (3 months)949,400
Market cap$1.5B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+1.51%
Earnings growth (this year)+68.48%
Earnings growth (next 5 years)+28.70%
Revenue growth (last year)-5.90%
P/E ratioNM
Price/Sales1.54
Price/Book7.87

Competitors

 Today’s
change
Today’s
% change
LXRXLexicon Pharmaceutic...+0.05+0.60%
RGENRepligen Corp+0.19+0.51%
ARRYArray Biopharma Inc-0.35-2.42%
EBSEmergent BioSolution...-0.12-0.22%
Data as of 4:02pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)$0.19
Annual revenue (last year)$775.8M
Annual profit (last year)-$469.3M
Net profit margin-60.49%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Paul M. Bisaro
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts